Cell Culture Models of Human Norovirus: the End of the Beginning?

키워드

참고문헌 (102)

1. Baltimore D, "Viral genetic systems", Trans. N. Y. Acad. Sci, 33, pp.327~332 (1971)
2. Green KY, "Fields virology, vol. 1", pp.949~980 (2007), Lippincott, Williams & Wilkins
3. Kapikian AZ, "The discovery of the 27-nm Norwalk virus:an historic perspective", J. Infect. Dis, 181(Suppl 2), pp.S295~S302 (2000)
4. Kapikian AZ, "Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis", J. Virol, 10, pp.1075~1081 (1972)
5. Prasad BV, "X-ray crystallographic structure of the Norwalk virus capsid", Science, 286, pp.287~290 (1999)
6. Ahmed SM, "Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis", Lancet. Infect. Dis, 14, pp.725~730 (2014)
7. Teunis PFM, "Norwalk virus: How infectious is it?", J. Med. Virol, 80, pp.1468~1476 (2008)
8. Atmar RL, "Norwalk virus shedding after experimental human infection", Emerg. Infect. Dis, 14, pp.1553~1557 (2008)
9. Esposito S, "Pediatric norovirus infection", Eur. J. Clin. Microbiol. Infect. Dis, 33, pp.285~290 (2014)
10. Patel MM, "Systematic literature review of role of noroviruses in sporadic gastroenteritis", Emerg. Infect. Dis, 14, pp.1224~1231 (2008)
11. Newman KL, "Norovirus in symptomatic and asymptomatic individuals:cytokines and viral shedding", Clin. Exp. Immunol, 184, pp.347~357 (2016)
12. Lee RM, "Incubation periods of viral gastroenteritis: a systematic review", BMC Infect. Dis, 13, pp.446~ (2013)
13. Bok K, "Norovirus gastroenteritis in immunocompromised patients", N. Engl. J. Med, 367, pp.2126~2132 (2012)
14. Lopman BA, "Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000", Emerg. Infect. Dis, 9, pp.71~77 (2003)
15. Yen C, "Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States", Clin. Infect. Dis, 53, pp.568~571 (2011)
16. de Wit MA, "Risk factors for norovirus, Sapporo-like virus, and group A rotavirus gastroenteritis", Emerg. Infect. Dis, 9, pp.1563~1570 (2003)
17. Phillips G, "Risk factors for symptomatic and asymptomatic norovirus infection in the community", Epidemiol. Infect, 139, pp.1676~1686 (2011)
18. Asanaka M, "Replication and packaging of Norwalk virus RNA in cultured mammalian cells", Proc. Natl. Acad. Sci. USA, 102, pp.10327~10332 (2005)
19. Katayama K, "Investigation of norovirus replication in a human cell line", Arch. Virol, 151, pp.1291~1308 (2006)
20. Lambden PR, "Sequence and genome organization of a human small round-structured (Norwalk-like) virus", Science, 259, pp.516~519 (1993)
21. Wyatt RG, "Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers", J. Infect. Dis, 129, pp.709~714 (1974)
22. Parrino TA, "Clinical immunity in acute gastroenteritis caused by norwalk agent", N. Engl. J. Med, 297, pp.86~89 (1977)
23. Johnson PC, "Multiple-challenge study of host susceptibility to norwalk gastroenteritis in US adults", J. Infect. Dis, 161, pp.18~21 (1990)
24. Agus SG, "Acute infectious nonbacterial gastroenteritis: Intestinal histopathology:histologic and enzymatic alterations during illness produced by the norwalk agent in man", Ann. Int. Med, 79, pp.18~25 (1973)
25. Jean J, "Inactivation of hepatitis A virus and norovirus surrogate in suspension and on food-contact surfaces using pulsed UV light (pulsed light inactivation of food-borne viruses)", Food Microbiol, 28, pp.568~572 (2011)
26. Park GW, "Inactivation of murine norovirus, feline calicivirus and echovirus 12 as surrogates for human norovirus (NoV) and coliphage (F+) MS2 by ultraviolet light (254 nm) and the effect of cell association on UV inactivation", Lett. Appl. Microbiol, 52, pp.162~167 (2011)
27. Duizer E, "Laboratory efforts to cultivate noroviruses", J. Gen. Virol, 85, pp.79~87 (2004)
28. Lay MK, "Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans", Virology, 406, pp.1~11 (2010)
29. Herbst-Kralovetz MM, "Lack of norovirus replication and histoblood group antigen expression in 3-dimensional intestinal epithelial cells", Emerg. Infect. Dis, 19, pp.431~438 (2013)
30. Papafragkou E, "Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models", PLoS One, 8, pp.e63485~ (2013)
31. Cubitt WD, "Propagation of human candidate calicivirus in cell culture", J. Gen. Virol, 65, pp.1123~1126 (1984)
32. Gauthier R, "Human intestinal epithelial cell survival: differentiation state-specific control mechanisms", Am. J. Physiol Cell Physiol, 280, pp.C1540~C1554 (2001)
33. Goke M, "Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor", Am. J. Physiol, 274, pp.G809~G818 (1998)
34. Hughes JH, "Physical and chemical methods for enhancing rapid detection of viruses and other agents", Clin. Microbiol. Rev, 6, pp.150~175 (1993)
35. Joshi SS, "Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines in culture", Cancer. Detect. Prev, 8, pp.237~245 (1985)
36. Lamartina S, "Lipofection of purified adeno-associated virus Rep68 protein:toward a chromosome-targeting nonviral particle", J. Virol, 72, pp.7653~7658 (1998)
37. Maitreyi RS, "Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections", J. Clin. Virol, 16, pp.41~47 (2000)
38. Pintó RM, "Use of the colonic carcinoma cell line CaCo-2 for in vivo amplification and detection of enteric viruses", J. Med. Virol, 44, pp.310~315 (1994)
39. Quaroni A, "Glucocorticoids have pleiotropic effects on small intestinal crypt cells", Am. J. Physiol, 277, pp.G1027~G1040 (1999)
40. Seno M, "Enhanced Isolation of influenza virus in conventional plate cell cultures by using low-speed centrifugation from clinical specimens", Am. J. Clin. Pathol, 95, pp.765~768 (1991)
41. Svensson L, "Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells", J. Virol, 65, pp.4190~4197 (1991)
42. Wobus CE, "Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages", PLOS Biol, 2, pp.e432~ (2004)
43. Wobus CE, "Murine norovirus: a model system to study norovirus biology and pathogenesis", J. Virol, 80, pp.5104~5112 (2006)
44. Elftman MD, "Multiple effects of dendritic cell depletion on murine norovirus infection", J. Gen. Virol, 94, pp.1761~1768 (2013)
45. Gonzalez-Hernandez MB, "Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells", J. Virol, 88, pp.6934~6943 (2014)
46. Gonzalez-Hernandez MB, "Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M-like cells", J. Virol, 87, pp.12685~12693 (2013)
47. Carterson AJ, "A549 Lung epithelial cells grown as three-dimensional aggregates: Alternative tissue culture model for pseudomonas aeruginosa pathogenesis", Infect. Imm, 73, pp.1129~1140 (2005)
48. Noel G, "A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions", Scient. Rep, 7, pp.45270~ (2017)
49. Honer zu Bentrup K, "Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis", Microbes Infect, 8, pp.1813~1825 (2006)
50. LaMarca HL, "Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion", Placenta, 26, pp.709~720 (2005)
51. Long JP, "Epstein-barr virus latently infected cells are selectively deleted in simulated-microgravity cultures", In Vitro Cell Dev. Biol. Anim, 37, pp.223~230 (2001)
52. Nickerson CA, "Three-dimensional tissue assemblies:novel models for the study of salmonella enterica serovar typhimurium pathogenesis", Infect. Imm, 69, pp.7106~7120 (2001)
53. Zhang S, "Beyond the Petri dish", Nat. Biotechnol, 22, pp.151~152 (2004)
54. Nickerson CA, "Studying host-pathogen interactions in 3-D: organotypic models for infectious disease and drug development", J. Neuroimm. Pharmacol, 2, pp.26~31 (2007)
55. Straub TM, "In vitro cell culture infectivity assay for human noroviruses", Emerg. Infect. Dis, 13, pp.396~403 (2007)
56. Straub TM, "Human norovirus infection of caco-2 cells grown as a 3-dimensional tissue structure", J. Water Health, 9, pp.225~240 (2011)
57. Takanashi S, "Failure of propagation of human norovirus in intestinal epithelial cells with microvilli grown in three-dimensional cultures", Arch Virol, 159, pp.257~266 (2014)
58. Mumphrey SM, "Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses", J. Virol, 81, pp.3251~3263 (2007)
59. Basic M, "Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice", Inflamm. Bowel Dis, 20, pp.431~443 (2014)
60. Zhu S, "Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains", PLoS Pathog, 9, pp.e1003592~ (2013)
61. Bok K, "Chimpanzees as an animal model for human norovirus infection and vaccine development", Proc. Natl. Acad. Sci. USA, 108, pp.325~330 (2011)
62. Jones MK, "Enteric bacteria promote human and mouse norovirus infection of B cells", Science, 346, pp.755~759 (2014)
63. Jones MK, "Human norovirus culture in B cells", Nat. Protoc, 10, pp.1939~1947 (2015)
64. Kuss SK, "Intestinal microbiota promote enteric virus replication and systemic pathogenesis", Science, 334, pp.249~252 (2011)
65. Kane M, "Successful transmission of a retrovirus depends on the commensal microbiota", Science, 334, pp.245~249 (2011)
66. Robinson CM, "Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus", Cell. Host. Microbe, 15, pp.36~46 (2014)
67. Baldridge MT, "Commensal microbes and interferonlambda determine persistence of enteric murine norovirus infection", Science, 347, pp.266~269 (2015)
68. Ha S, "Infection models of human norovirus: challenges and recent progress", Arch. Virol, 161, pp.779~788 (2016)
69. Grimprel E, "Rotavirus disease:impact of coinfections", Pediat. Infect. Dis. J, 27, pp.S3~S10 (2008)
70. Jessica Wilks, "Dual role of commensal bacteria in viral infections", Immunological Reviews, 255(1), pp.222~229 (2013), Wiley-Blackwell[DOI]
71. Miura T, "Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses", J. Virol, 87, pp.9441~9451 (2013)
72. Marionneau S, "Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals", Gastroenterology, 122, pp.1967~1977 (2002)
73. Tan M, "Histo-blood group antigens: a common niche for norovirus and rotavirus", Expert. Rev. Mol. Med, 16, pp.e5~ (2014)
74. Huang P, "Noroviruses bind to human ABO, Lewis, secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns", J. Infect. Dis, 188, pp.19~31 (2003)
75. Sestak K, "Role of histo-blood group antigens in primate enteric calicivirus infections", World J. Virol, 3, pp.18~21 (2014)
76. Hutson AM, "Norwalk virus infection and disease is associated with ABO histo-blood group type", J. Infect. Dis, 185, pp.1335~1337 (2002)
77. Hutson AM, "Norwalk virus infection associates with secretor status genotyped from sera", J. Med. Virol, 77, pp.116~120 (2005)
78. Karst SM, "Pathogenesis of noroviruses, emerging RNA viruses", Viruses, 2, pp.748~781 (2010)
79. Lindesmith L, "Human susceptibility and resistance to Norwalk virus infection", Nat. Med, 9, pp.548~553 (2003)
80. Marionneau S, "Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment", J. Infect. Dis, 192, pp.1071~1077 (2005)
81. Zhang X-F, "Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections", PLoS One, 8, pp.e69379~ (2013)
82. Almagro-Moreno S, "Bacterial catabolism of nonulosonic (sialic) acid and fitness in the gut", Gut. Microbes, 1, pp.45~50 (2010)
83. Bally M, "Norovirus GII.4 virus-like particles recognize galactosylceramides in domains of planar supported lipid bilayers", Angew. Chem. Int. Ed. Engl, 51, pp.12020~12024 (2012)
84. Rydell GE, "Human noroviruses recognize sialyl Lewis x neoglycoprotein", Glycobiology, 19, pp.309~320 (2009)
85. Tamura M, "Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane", J. Virol, 78, pp.3817~3826 (2004)
86. Orchard RC, "Discovery of a proteinaceous cellular receptor for a norovirus", Science, 353, pp.933~936 (2016)
87. Lei S, "Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs", Scientif. Rep, 6, pp.25017~ (2016)
88. Cheetham S, "Pathogenesis of a genogroup ii human norovirus in gnotobiotic pigs", J. Virol, 80, pp.10372~10381 (2006)
89. Jung K, "The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of Antivirals", PLoS One, 7, pp.e41619~ (2012)
90. Bui T, "Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age", J. Gen. Virol, 94, pp.2005~2016 (2013)
91. Brown JR, "Norovirus Infections Occur in B-Cell-Deficient Patients", Clin. Infect. Dis, 62, pp.1136~1138 (2016)
92. Green KY, "Editorial commentary: noroviruses and B cells", Clin. Infect. Dis, 62, pp.1139~1140 (2016)
93. Saxena K, "Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology", J. Virol, 90, pp.43~56 (2015)
94. Ettayebi K, "Replication of human noroviruses in stem cell-derived human enteroids", Science, 353, pp.1387~1393 (2016)
95. Weber F, "Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses", J. Virol, 80, pp.5059~5064 (2006)
96. Monaghan P, "Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-andmouth disease virus", J. Virol, 79, pp.6410~6418 (2005)
97. Paddock SW, "Confocal Microscopy: Methods and Protocols" (1999), Humana Press
98. Hofmann AF, "Biliary secretion and excretion in health and disease: current concepts", Ann. Hepatol, 6, pp.15~27 (2007)
99. Hofmann AF, "Enterohepatic circulation of bile acids and biliary lipid secretion", Minerva Med, 68, pp.3011~3017 (1977)
100. Ruvoën-Clouet N, "Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution", Rev. Med. Virol, 23, pp.355~366 (2013)
101. Thorven M, "A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections", J. Virol, 79, pp.15351~15355 (2005)
102. Kelly RJ, "Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype", J. Biol. Chem, 270, pp.4640~4649 (1995)

관련 논문AI추천